Cronos Group Inc. (CRON)
Stock Price:
$6.32 USD
0.30 (4.98%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
Pre-market: $6.29 -0.03 (-0.48%) Jul 10, 7:56 PM
Key Info
| Market Cap |
2.20B |
| Revenue (ttm) |
29.18M |
| Net Income (ttm) |
913.33M |
| Shares Out |
348.82M |
| EPS (ttm) |
2.71 |
| PE Ratio |
2.33 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 10, 2020 |
| Last Price |
$6.32 |
| Previous Close |
$6.02 |
| Change ($) |
0.30 |
| Change (%) |
4.98% |
| Day's Open |
6.01 |
| Day's Range |
6.01 - 6.40 |
| Day's Volume |
3,646,719 |
| 52-Week Range |
4.00 - 15.85 |
More Stats
| Market Cap |
2.20B |
| Enterprise Value |
876.54M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
348.82M |
| Float |
182.75M |
| EPS (basic) |
2.557 |
| EPS (diluted) |
2.71 |
| FCF / Share |
-0.54 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
42.88% |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
45.72M |
| Short Ratio |
5.41 |
| Short % of Float |
26.72% |
| Beta |
1.91 |
| PE Ratio |
2.33 |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
75.56 |
| PB Ratio |
1.27 |
| Revenue |
29.18M |
| Operating Income |
-166.04M |
| Net Income |
913.33M |
| Free Cash Flow |
-189.37M |
| Net Cash |
1.33B |
| Net Cash / Share |
3.81 |
| Gross Margin |
-54.71% |
| Operating Margin |
-569.05% |
| Profit Margin |
3,137.50% |
| FCF Margin |
-649.00% |
| ROA |
-4.89% |
| ROE |
75.98% |
| ROIC |
628.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (14)
| Buy |
2 |
| Overweight |
2 |
| Hold |
8 |
| Underweight |
0 |
| Sell |
2 |
Analyst Consensus: Overweight
Price Target
$6.07*
(-3.96% downside)
Low
4.28
Current: 6.32
High
8.00
Target: 6.07
*Average 12-month price target from 13 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Revenue | 23.75 | 12.12 | 3.15 | 0.43 | - |
| Revenue Growth | 95.94% | 285.16% | 638.69% | - | - |
| Gross Profit | -17.86 | 6.21 | 1.57 | 1.53 | -0.15 |
| Operating Income | -121 | -21.34 | -6.12 | -1.64 | -1.74 |
| Net Income | 1,167 | -21.64 | -1.48 | -0.92 | 0.30 |
| Shares Outstanding | 310 | 172 | 135 | 60.17 | 28.00 |
| Earnings Per Share | 3.33 | -0.13 | -0.01 | -0.02 | 0.01 |
| Operating Cash Flow | -130 | -7.52 | -4.28 | -4.98 | -1.06 |
| Capital Expenditures | -38.66 | -88.31 | -32.93 | -1.17 | -1.16 |
| Free Cash Flow | -169 | -95.83 | -37.20 | -6.15 | -2.22 |
| Cash & Equivalents | 1,511 | 24.16 | 7.32 | 2.90 | 0.87 |
| Total Debt | 7.11 | 0.12 | 4.13 | 3.08 | 1.20 |
| Net Cash / Debt | 1,504 | 24.04 | 3.20 | -0.17 | -0.34 |
| Assets | 2,090 | 183 | 77.69 | 32.99 | 11.32 |
| Liabilities | 341 | 34.92 | 11.27 | 7.09 | 2.32 |
| Book Value | 1,750 | 148 | 66.42 | 25.90 | 9.00 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Cronos Group Inc. |
| Country |
Canada |
| Employees |
631 |
| CEO |
Michael Ryan Gorenstein |
Stock Information
| Ticker Symbol |
CRON |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
NASDAQ: CRON |
Description
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.